Regeneron convinces PTAB to review Novartis syringe patent

The US Patent Trial and Appeal Board (PTAB) has granted a review of a Novartis syringe patent following a challenge from biotech giant Regeneron.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Kirkland & Ellis adds leading barrister in London

1 June 2026 The new hire brings nearly two decades of trial experience in complex disputes across patents, trademarks, copyright and confidential information, including landmark patent litigation before the UK Supreme Court.

Americas

Federal Circuit tosses $59m trade secrets judgment against EOFlow

29 May 2026 A US appeals court has thrown out a jury verdict against a South Korean medical device company, ruling that Insulet waited too long to bring its trade secret misappropriation claim.

Careers

Neal Gerber Eisenberg expands in Chicago with new litigator

28 May 2026 The Chicago firm has added a partner with experience across patent litigation and strategic counselling for clients in the pharma, biotech, and advanced technology sectors.

More features

Kirkland & Ellis adds leading barrister in London

Federal Circuit tosses $59m trade secrets judgment against EOFlow

Neal Gerber Eisenberg expands in Chicago with new litigator

European court backs AstraZeneca unit in blood cancer combo dispute

Takeda’s China IP head: What pharma is still getting wrong

Boehringer Ingelheim adds ex-Teva executive to patent team

AI, anxiety, and antibodies: The issues dominating life sciences

UPC judge: ‘Expectations of you as a woman are the challenge’

Regeneron convinces PTAB to review Novartis syringe patent

More on this story

Editor's picks

Editor's picks

More features